Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level

9. Juli 2026 aktualisiert von: Ankara Yildirim Beyazıt University
This randomized controlled experimental study was conducted to evaluate the effects of virtual reality glasses used during hemodialysis on patients' vital signs and anxiety levels. A total of 56 adult patients receiving hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital were randomly assigned to either an experimental group or a control group. Patients in the experimental group watched a 4K virtual reality nature video with relaxing background music during hemodialysis, while the control group received standard hemodialysis care. Vital signs, pain, anxiety, and satisfaction were assessed to evaluate the effectiveness of the virtual reality intervention.

Studienübersicht

Detaillierte Beschreibung

The research was designed and conducted as a randomized controlled experimental study to determine the effects of virtual reality glasses on the vital signs and anxiety levels of hemodialysis patients.

The study population consisted of patients diagnosed with kidney failure who received hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between May 2023 and May 2024. A total of 56 patients who volunteered to participate and met the inclusion criteria were included in the study. These patients were randomly assigned to two homogeneous groups according to gender and type of renal failure (acute/chronic): an experimental group (n=28) and a control group (n=28).

Patients in the experimental group watched a 4K virtual reality video featuring natural scenery accompanied by relaxing background music through virtual reality glasses during hemodialysis, whereas patients in the control group received standard hemodialysis care without any additional intervention.

Data were collected using the Patient Information Form, Vital Signs Follow-up Form, Visual Analog Scale for Pain (VAS), State Anxiety Scale, and Visual Analog Scale for Satisfaction (VAS-Satisfaction). Ethics committee approval, institutional permission, and written informed consent were obtained before the study was conducted.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

56

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

      • Ankara, Türkei (türkiye), 06200
        • Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

  • Receiving hemodialysis treatment for the first time.
  • Age ≥18 years.
  • No visual, hearing, or cognitive impairment.
  • Able to communicate effectively.
  • Clinically stable.
  • No diagnosed psychiatric disorder or use of psychiatric medication.
  • No history of seizures.
  • Willing and able to provide informed consent.

Exclusion Criteria:

  • Previous hemodialysis treatment.
  • Age <18 years.
  • Visual, hearing, or cognitive impairment.
  • History of kidney transplantation.
  • Communication difficulties.
  • Diagnosed psychiatric disorder or use of psychiatric medication.
  • History of seizures.
  • Declined to participate in the study.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Experimental Group
Participants received a virtual reality intervention during hemodialysis in addition to standard care.
Participants wore virtual reality glasses at the start of the hemodialysis session and viewed a 4K nature video with calming background music for 15 minutes. The intervention was administered once during the hemodialysis session in addition to standard hemodialysis care.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
Aktiver Komparator: Control Group
Participants received standard hemodialysis care without any additional intervention.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Systolic Blood Pressure
Zeitfenster: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in systolic blood pressure measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Diastolic Blood Pressure
Zeitfenster: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in diastolic blood pressure measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Heart Rate
Zeitfenster: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in heart rate measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Respiratory Rate
Zeitfenster: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in respiratory rate measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Peripheral Oxygen Saturation (SpO₂)
Zeitfenster: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in peripheral oxygen saturation (SpO₂) measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Body Temperature
Zeitfenster: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in body temperature measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
State Anxiety Level After Hemodialysis
Zeitfenster: Immediately after completion of the hemodialysis session.
State anxiety measured using the State Anxiety Inventory (STAI-State), a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety. Assessment was performed immediately after completion of the hemodialysis session.
Immediately after completion of the hemodialysis session.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Pain Score
Zeitfenster: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in pain score measured using the Visual Analog Scale for Pain (VAS-P), a 0-10 scale where 0 indicates no pain and 10 indicates the worst possible pain. Higher scores indicate greater pain. Pain was assessed before and immediately after completion of the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Participant Satisfaction Score
Zeitfenster: Immediately after completion of the hemodialysis session.
Participant satisfaction with the virtual reality intervention measured using the Visual Analog Scale for Satisfaction (VAS-S), a 0-10 scale where 0 indicates not satisfied at all and 10 indicates completely satisfied. Higher scores indicate greater participant satisfaction. Assessment was performed immediately after completion of the hemodialysis session.
Immediately after completion of the hemodialysis session.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Studienleiter: Hilal Tüzer, Assoc. Prof., Ankara Yildirim Beyazıt University

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

3. Mai 2023

Primärer Abschluss (Tatsächlich)

27. Mai 2024

Studienabschluss (Tatsächlich)

27. Mai 2024

Studienanmeldedaten

Zuerst eingereicht

28. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

9. Juli 2026

Zuerst gepostet (Tatsächlich)

15. Juli 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

15. Juli 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

9. Juli 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Beschreibung des IPD-Plans

The decision regarding sharing of individual participant data has not yet been finalized. Any future data sharing will be considered in accordance with institutional policies, ethical requirements, and applicable regulations.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren